ID27554A - Formulasi-formulasi sediaan farmasi untuk aerosol dengan dua atau lebih bahan aktif - Google Patents

Formulasi-formulasi sediaan farmasi untuk aerosol dengan dua atau lebih bahan aktif

Info

Publication number
ID27554A
ID27554A IDW20002641A ID20002641A ID27554A ID 27554 A ID27554 A ID 27554A ID W20002641 A IDW20002641 A ID W20002641A ID 20002641 A ID20002641 A ID 20002641A ID 27554 A ID27554 A ID 27554A
Authority
ID
Indonesia
Prior art keywords
aerosols
active materials
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
IDW20002641A
Other languages
English (en)
Indonesian (id)
Inventor
Daniel P Mcnamara
George A De Stefano
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26046888&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID27554(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1998127178 external-priority patent/DE19827178A1/de
Priority claimed from DE1998142963 external-priority patent/DE19842963A1/de
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ID27554A publication Critical patent/ID27554A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW20002641A 1998-06-18 1999-06-08 Formulasi-formulasi sediaan farmasi untuk aerosol dengan dua atau lebih bahan aktif ID27554A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1998127178 DE19827178A1 (de) 1998-06-18 1998-06-18 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen
DE1998142963 DE19842963A1 (de) 1998-09-19 1998-09-19 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen

Publications (1)

Publication Number Publication Date
ID27554A true ID27554A (id) 2001-04-12

Family

ID=26046888

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002641A ID27554A (id) 1998-06-18 1999-06-08 Formulasi-formulasi sediaan farmasi untuk aerosol dengan dua atau lebih bahan aktif

Country Status (33)

Country Link
EP (1) EP1087750B1 (no)
JP (1) JP2003522102A (no)
KR (1) KR100600423B1 (no)
CN (1) CN1161104C (no)
AR (1) AR019690A1 (no)
AT (1) ATE253896T1 (no)
AU (1) AU759222B2 (no)
BG (1) BG65252B1 (no)
BR (1) BR9911351A (no)
CA (1) CA2335065C (no)
CO (1) CO5070580A1 (no)
CZ (1) CZ300910B6 (no)
DE (1) DE69912781T2 (no)
DK (1) DK1087750T3 (no)
EE (1) EE04450B1 (no)
ES (1) ES2211108T3 (no)
HK (1) HK1037974A1 (no)
HR (1) HRP20000867B1 (no)
HU (1) HU229064B1 (no)
ID (1) ID27554A (no)
IL (2) IL140353A0 (no)
ME (1) ME00838B (no)
MY (1) MY121073A (no)
NO (1) NO329416B1 (no)
NZ (1) NZ509418A (no)
PL (1) PL193695B1 (no)
PT (1) PT1087750E (no)
RS (1) RS49977B (no)
RU (1) RU2218152C2 (no)
SK (1) SK284756B6 (no)
TR (1) TR200003721T2 (no)
TW (1) TW528606B (no)
WO (1) WO1999065464A1 (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB2332372B (en) * 1997-12-08 2002-08-14 Minnesota Mining & Mfg Pharmaceutical aerosol compositions
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6479035B1 (en) 1999-09-11 2002-11-12 Smithkline Beecham Corporation Pharmaceutical formulation of fluticasone propionate
ATE286716T1 (de) * 1999-11-23 2005-01-15 Glaxo Group Ltd Pharmazeutische formulierungen enthaltend salmeterol
EP1248597B1 (en) * 1999-12-24 2005-03-30 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0008485D0 (en) * 2000-04-07 2000-05-24 Glaxo Group Ltd Pharmaceutical compositions
BR0015884A (pt) 2000-05-22 2003-07-08 Chiesi Farma Spa Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
EP1446119B1 (en) 2001-09-18 2006-03-01 Nycomed Danmark ApS Compositions comprising ipatropium and xylometazoline for treatment of the common cold
JP2010184937A (ja) * 2001-10-26 2010-08-26 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する１容器を作成する方法、および、吸入溶液を作成する方法
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US9308199B2 (en) * 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CN101175479A (zh) * 2005-03-16 2008-05-07 霍尼韦尔国际公司 药物递送制剂、装置和方法
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US8061350B2 (en) 2006-06-02 2011-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process and device for dosing pharmaceutical agents
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
ES2298049B1 (es) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2408500B1 (en) 2009-03-17 2015-04-29 Boehringer Ingelheim International GmbH Dispensing device, and storage device for dispensing a formulation
JP5670421B2 (ja) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング コンポーネント表面のコーティング方法
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
CN104225735B (zh) 2009-11-25 2018-12-07 贝林格尔.英格海姆国际有限公司 喷雾器
US20120272951A1 (en) 2009-12-16 2012-11-01 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
JP6559157B2 (ja) 2014-05-07 2019-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
KR102443737B1 (ko) 2014-05-07 2022-09-19 베링거 인겔하임 인터내셔날 게엠베하 컨테이너, 분무기 및 사용 방법
BR112016023719B1 (pt) 2014-05-07 2021-12-21 Boehringer Ingelheim International Gmbh Nebulizador para um fluido e recipiente para um nebulizador
WO2020152548A1 (en) * 2019-01-24 2020-07-30 Glenmark Pharmaceuticals Limited Stable aerosol inhalation compositions of formoterol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
RU2126248C1 (ru) * 1992-12-09 1999-02-20 Берингер Ингельхейм Фармасьютикалз, Инк. Жидкая фармацевтическая композиция в форме аэрозоля
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
US5603918A (en) * 1995-06-09 1997-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. Aerosol composition of a salt of ipratropium and a salt of albuterol
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物

Also Published As

Publication number Publication date
HRP20000867B1 (en) 2010-10-31
RS49977B (sr) 2008-09-29
MY121073A (en) 2005-12-30
EP1087750B1 (en) 2003-11-12
ME00838B (me) 2008-09-29
PT1087750E (pt) 2004-02-27
NO329416B1 (no) 2010-10-18
HRP20000867A2 (en) 2001-10-31
WO1999065464A1 (en) 1999-12-23
DE69912781T2 (de) 2004-10-21
KR100600423B1 (ko) 2006-07-13
CZ20004750A3 (en) 2001-05-16
CA2335065C (en) 2008-06-03
NO20006318L (no) 2001-01-30
HUP0104734A3 (en) 2003-05-28
TR200003721T2 (tr) 2001-06-21
AR019690A1 (es) 2002-03-13
BR9911351A (pt) 2001-03-13
EE04450B1 (et) 2005-04-15
JP2003522102A (ja) 2003-07-22
KR20010072621A (ko) 2001-07-31
CO5070580A1 (es) 2001-08-28
HK1037974A1 (en) 2002-03-01
YU80000A (sh) 2003-04-30
RU2218152C2 (ru) 2003-12-10
SK19392000A3 (sk) 2001-07-10
BG105033A (en) 2001-09-28
NO20006318D0 (no) 2000-12-12
CN1161104C (zh) 2004-08-11
AU4552199A (en) 2000-01-05
PL193695B1 (pl) 2007-03-30
AU759222B2 (en) 2003-04-10
HUP0104734A2 (hu) 2002-05-29
HU229064B1 (en) 2013-07-29
ES2211108T3 (es) 2004-07-01
EE200000759A (et) 2002-04-15
IL140353A0 (en) 2002-02-10
ATE253896T1 (de) 2003-11-15
EP1087750A1 (en) 2001-04-04
BG65252B1 (bg) 2007-10-31
CA2335065A1 (en) 1999-12-23
NZ509418A (en) 2003-06-30
SK284756B6 (sk) 2005-11-03
DE69912781D1 (de) 2003-12-18
CN1307470A (zh) 2001-08-08
CZ300910B6 (cs) 2009-09-09
PL345685A1 (en) 2002-01-02
DK1087750T3 (da) 2004-01-26
IL140353A (en) 2006-09-05
TW528606B (en) 2003-04-21

Similar Documents

Publication Publication Date Title
ID27554A (id) Formulasi-formulasi sediaan farmasi untuk aerosol dengan dua atau lebih bahan aktif
DK1073417T3 (da) Farmaceutisk aerosolformulering
ATE222751T1 (de) Pharmazeutische aerosolzusammensetzung
DE69530325D1 (de) Aerosol-arzneiformulierungen
DK1001813T3 (da) Farmaceutiske formuleringer indeholdende voriconazol
DE69812089D1 (de) Pharmazeutische omeprazol-formulierung
ID23299A (id) Formulasi-formulasi farmasi
NO991407D0 (no) Legemiddelaerosolformuleringer som omfatter budesonid
ID27150A (id) Sediaan levotiroksin bahan farmasi
DE69830154D1 (de) Pharmazeutische zusammensetzungen
ID30032A (id) Formulasi farmasi
SI1087750T1 (en) Pharmaceutical formulations for aerosols with two or more active substances
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
SE9803952D0 (sv) Pharmaceutical formulation